Young Hee Ko

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention

Peter L. Pedersen, Saroj P. Mathupala, Annette Rempel et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics · 2002 · 351 citations

Life Sciences, Molecular Biology, Oncology +10

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP

Young Hee Ko, Barbara L. Smith, Yuchuan Wang et al. · Biochemical and Biophysical Research Communications · 2004 · 351 citations

Medicine, Cancer Biology, Oncology +12

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

Young Hee Ko, Peter L. Pedersen, J.F. Geschwind · Cancer Letters · 2001 · 346 citations

Medicine, Biochemistry, Oncology +16

Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.

J.F. Geschwind, Young Hee Ko, Michael Torbenson et al. · PubMed · 2002 · 257 citations

Medicine, Oncology, Pharmacology +16

Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K ⁺ channel activity

Hossein Ardehali, Zhenhui Chen, Young Hee Ko et al. · Proceedings of the National Academy of Sciences · 2004 · 216 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17